Prostate Cancer - Results from #21020

Survey of high-dose-rate prostate brachytherapy practice in Australia and New Zealand, 2010-2011 - Abstract March 14, 2014

Prostate cancer and quality of life: Analysis of response shift using triangulation between methods - Abstract March 14, 2014

Implementing the use of nomograms by choosing threshold points in predictive models: 2012 Updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer - Abstract March 14, 2014

Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer - Abstract March 13, 2014

Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: New clinical trial designs should be considered - Abstract March 13, 2014

Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer - Abstract March 13, 2014

Non-apical positive surgical margins after radical prostatectomy for pT2 prostate cancer is associated with the highest risk of recurrence - Abstract March 13, 2014

National trends in prostate cancer screening among older American men with limited 9-year life expectancies: Evidence of an increased need for shared decision making - Abstract March 13, 2014

Identification of underserved areas for urologic cancer care - Abstract March 13, 2014

Localized prostate cancer in Norway, the United States, and Spain: Between-country differences of variables before treatment among patients eligible for curative treatment - Abstract March 13, 2014

Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence - Abstract March 13, 2014

Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy - Abstract March 13, 2014

Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP) - Abstract March 13, 2014

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: Results from SWOG 0421 - Abstract March 13, 2014

Dendreon announces plans to make PROVENGE® commercially available in Europe March 13, 2014

Zoledronic acid treatment for cancerous bone metastases: A phase IV study in Taiwan - Abstract March 12, 2014

Multi-parametric magnetic resonance imaging guiding diagnostic biopsy detects significant prostate cancer, and could reduce unnecessary biopsies and over-detection: A prospective study - Abstract March 12, 2014

Statin drug use is not associated with prostate cancer risk in men who are regularly screened - Abstract March 12, 2014

A tertiary Gleason pattern in the prostatectomy specimen and its association to adverse outcome after radical prostatectomy; results of a large contemporary prostatectomy series - Abstract March 12, 2014

The roles of multiparametric MRI, PCA3, and PHI: Which is the best predictor of prostate cancer after a negative biopsy? Results of a prospective study - Abstract March 12, 2014

Page 1052 of 1436